Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon

  1. Home

  • Monday, Dec 4th
    3:45 PM – 4:45 PM ET
    C15 - [IN-PERSON/RECORDED] The Current State of the Use of Dogs in Research
    Location: Room 146 ABC
    Speaker: Ernst Heinen (he/him/his) – Elanco Animal Health
    Speaker: Rod Christmas (he/him/his) – Boehringer Ingelheim Animal Health
    Speaker: Naomi Charalambakis, PhD (she/her/hers) – Federation of American Societies for Experimental Biology (FASEB)
    Speaker: Allison Thiede, DVM, DACLAM – AbbVie
    Pharma/Biotech PerspectivesCommunication With the PublicEmerging Research Challenges and Breaking Issues
  • Tuesday, Dec 5th
    1:00 PM – 2:00 PM ET
    D11 - [IN-PERSON ONLY] Translating Ethical Principles for the Responsible Use of Emerging Science and Technology Across a Global Pharmaceutical Company
    Location: Room 149 AB
    Speaker: Missy Heidelberg, B.S., M.S. Bioethics (she/her/hers) – Takeda Pharmaceuticals
    Speaker: Lindsay McNair, MD, MPH, MSB (she/her/hers) – Equipoise Consulting, LLC
    Speaker: David H. Strauss, MD – Columbia University
    Speaker: Karla Childers, BA, MSJ, MS (she/her/hers) – Johnson & Johnson
    Pharma/Biotech PerspectivesEmerging Research Challenges and Breaking IssuesResearch Conducted in the Digital World
  • Tuesday, Dec 5th
    1:00 PM – 2:00 PM ET
    D16 - [IN-PERSON/RECORDED] FDA Modernization Act 2.0: Fact and Fiction
    Location: Room 206
    Speaker: Brandon Morton – National Association for Biomedical Research
    Speaker: Jim Newman (he/him/his) – Americans for Medical Progress
    Pharma/Biotech PerspectivesEmerging Research Challenges and Breaking Issues
  • Tuesday, Dec 5th
    1:00 PM – 2:00 PM ET
    D21 - [ON-DEMAND] Moving the Needle: The Marseilles Declaration‐‐What Is it?
    Presenter: Jennie Lofgren, DVM, MS, DACLAM (she/her/hers) – Novartis Institutes for Biomedical Research
    Presenter: Kerstin Kleinschmidt-Doerr, DVM, PhD, MBA (she/her/hers) – Merck KGaA, Darmstadt, Germany
    Pharma/Biotech Perspectives
  • Tuesday, Dec 5th
    2:30 PM – 3:45 PM ET
    [IN-PERSON/LIVESTREAMED] Plenary Session: It's About Time: Inclusion of Sexual and Gender Minorities in Clinical Research
    Location: Hall E
    Moderator: Christina N. Dragon, MSPH, CHES (she/her/hers) – National Institutes of Health (NIH)
    Panelist: Willyanne DeCormier Plosky, DrPH (she/her/hers) – Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard
    Panelist: Amy Ben-Arieh, JD, MPH – The Fenway Institute
    Panelist: Keith Dawson, DNP, MS (he/him/his) – Genentech
    Populations Requiring Additional ProtectionsAdvancing Equity and Justice in ResearchHRPP/IRB Administration/Management and ProcessPharma/Biotech Perspectives
  • Wednesday, Dec 6th
    10:15 AM – 11:15 AM ET
    F14 - [IN-PERSON/RECORDED] The Ethical Conduct of Cell and Gene Therapy Research: Novel Challenges for Industry and the IRB
    Location: Room 152B
    Speaker: Missy Heidelberg, B.S., M.S. Bioethics (she/her/hers) – Takeda Pharmaceuticals
    Speaker: David H. Strauss, MD – Columbia University
    Speaker: Susan Z. Kornetsky, MPH – Boston Children's Hospital
    Pharma/Biotech PerspectivesAdvancing Equity and Justice in ResearchEmerging Research Challenges and Breaking IssuesResearch Involving Data and Biospecimens
  • Wednesday, Dec 6th
    11:30 AM – 12:30 PM ET
    G01 - [IN-PERSON/RECORDED] Look Who's Doing Research Now! What Does it Mean for Walgreens, Walmart, Etc., to Be Conducting Human Subjects Research?
    Location: Room 145 AB
    Speaker: Adam Samson, MS, PMP, CCRA, CCRC, CCDM – Walgreens
    Speaker: Mark A. Munger, Dr. – University of Utah
    Pharma/Biotech PerspectivesEmerging Research Challenges and Breaking Issues
  • Wednesday, Dec 6th
    11:30 AM – 12:30 PM ET
    G16 - [IN-PERSON/RECORDED] ICH E6 Good Clinical Practice (GCP) Training: Programs‐‐Approaches to Achieving Training Compliance Certification for Researchers
    Location: Room 154 AB
    Speaker: Frederick W. Luthardt, Jr., D.Be., MA (he/him/his) – Johns Hopkins University School of Medicine
    Speaker: Jessica Rowe, MA, MS, CCRP, CIP (she/her/hers) – Yale Cancer Center, Clinical Trials Office
    Education, Qualifications, and TrainingHRPP/IRB Administration/Management and ProcessShared Research Oversight ChallengesPharma/Biotech Perspectives
  • Wednesday, Dec 6th
    1:45 PM – 2:45 PM ET
    H04 - [IN-PERSON/RECORDED] Eliminating Financial Barriers to Clinical Study Participation: The Need for Industry and Academic Partnership for a Sustainable Solution
    Location: Room 144 AB
    Speaker: Matt Stafford, MPH (he/him/his) – Yale University
    Speaker: Lindsay McNair, MD, MPH, MSB (she/her/hers) – Equipoise Consulting, LLC
    Speaker: Jaime O. Hernandez, JD, M.Be. (he/him/his) – Office for Human Research Protections (OHRP), Department of Health and Human Services (HHS)
    Pharma/Biotech PerspectivesAdvancing Equity and Justice in Research
  • Wednesday, Dec 6th
    1:45 PM – 2:45 PM ET
    H17 - [IN-PERSON/RECORDED] Balancing the Pressure of Getting New Therapies to Clinical Trial: Ensuring Robust Study Design, Nonhuman Animal Welfare, and Human Subjects Protections
    Location: Room 154 AB
    Speaker: David Litwack (he/him/his) – Prevail Therapeutics
    Speaker: Brad Ahrens, DVM, PhD – Labcorp
    Pharma/Biotech PerspectivesFlexibility and Innovation in Research Oversight Processes